Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suraj Samtani

Showing results (31-40 of 51) with videos related to

Pageof 6
Sort By:
BMC Cancer|August 6, 2021
RRM1 and ERCC1 as biomarkers in patients with locally advanced and metastatic malignant pleural mesothelioma treated with continuous infusion of low-dose gemcitabine plus cisplatinWendy Muñoz-Montaño, Sae Muñiz-Hernández, Alejandro Avilés-Salas, et al.
Nutrition and Cancer|June 3, 2020
The Role of a Cachexia Grading System in Patients with Non-Small Cell Lung Cancer Treated with Immunotherapy: Implications for SurvivalJenny G Turcott, Julio E Martinez-Samano, Andrés F Cardona, et al.
Ageing Research Reviews|April 5, 2026
How does social health impact cognitive function and brain reserve? Findings from the SHARED ConsortiumSuraj Samtani, Jean Stafford, Dorota Szcześniak, et al.
Frontiers in Psychiatry|October 4, 2024
Social health markers in the context of cognitive decline and dementia: an international qualitative studyMartina S Kristanti, Myrra Vernooij-Dassen, Yun-Hee Jeon, et al.
Lancet Regional Health. Americas|July 21, 2025
Clinical and economic impact of the availability of innovative therapies for advanced lung cancer in men in Latin America: a population-based secondary data studyAndrés F Cardona, Natalia Sánchez, Liliana Gutiérrez-Babativa, et al.
Lancet Regional Health. Americas|December 1, 2025
Corrigendum to "Clinical and economic impact of the availability of innovative therapies for advanced lung cancer in men in Latin America: a population-based secondary data study"- the Lancet Regional Health-Americas 2025; Volume 49: 101172; DOI: 10.1016/j.lana.2025.101172Andrés F Cardona, Natalia Sánchez, Liliana Gutiérrez-Babativ, et al.
Gerontology|July 27, 2023
Social Health and Change in Cognitive Capability among Older Adults: Findings from Four European Longitudinal StudiesJane Maddock, Federico Gallo, Frank J Wolters, et al.
Frontiers in Oncology|July 29, 2022
Durvalumab After Chemoradiation for Unresectable Stage III Non-Small Cell Lung Cancer: Inferior Outcomes and Lack of Health Equity in Hispanic Patients Treated With PACIFIC Protocol (LA1-CLICaP)Luis E Raez, Oscar Arrieta, Diego F Chamorro, et al.
The Lancet. Healthy Longevity|May 5, 2024
Social health and subsequent cognitive functioning in people aged 50 years and older: examining the mediating roles of depressive symptoms and inflammatory biomarkers in two European longitudinal studiesJean Stafford, Serhiy Dekhtyar, Anna-Karin Welmer, et al.
Brain Sciences|September 23, 2022
What Do We Know about Social and Non-Social Factors Influencing the Pathway from Cognitive Health to Dementia? A Systematic Review of ReviewsMarta Lenart-Bugla, Mateusz Łuc, Marcin Pawłowski, et al.
Pageof 6

Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
BMC Cancer|August 6, 2021
RRM1 and ERCC1 as biomarkers in patients with locally advanced and metastatic malignant pleural mesothelioma treated with continuous infusion of low-dose gemcitabine plus cisplatinWendy Muñoz-Montaño, Sae Muñiz-Hernández, Alejandro Avilés-Salas, et al.
Nutrition and Cancer|June 3, 2020
The Role of a Cachexia Grading System in Patients with Non-Small Cell Lung Cancer Treated with Immunotherapy: Implications for SurvivalJenny G Turcott, Julio E Martinez-Samano, Andrés F Cardona, et al.
Ageing Research Reviews|April 5, 2026
How does social health impact cognitive function and brain reserve? Findings from the SHARED ConsortiumSuraj Samtani, Jean Stafford, Dorota Szcześniak, et al.
Frontiers in Psychiatry|October 4, 2024
Social health markers in the context of cognitive decline and dementia: an international qualitative studyMartina S Kristanti, Myrra Vernooij-Dassen, Yun-Hee Jeon, et al.
Lancet Regional Health. Americas|July 21, 2025
Clinical and economic impact of the availability of innovative therapies for advanced lung cancer in men in Latin America: a population-based secondary data studyAndrés F Cardona, Natalia Sánchez, Liliana Gutiérrez-Babativa, et al.
Lancet Regional Health. Americas|December 1, 2025
Corrigendum to "Clinical and economic impact of the availability of innovative therapies for advanced lung cancer in men in Latin America: a population-based secondary data study"- the Lancet Regional Health-Americas 2025; Volume 49: 101172; DOI: 10.1016/j.lana.2025.101172Andrés F Cardona, Natalia Sánchez, Liliana Gutiérrez-Babativ, et al.
Gerontology|July 27, 2023
Social Health and Change in Cognitive Capability among Older Adults: Findings from Four European Longitudinal StudiesJane Maddock, Federico Gallo, Frank J Wolters, et al.
Frontiers in Oncology|July 29, 2022
Durvalumab After Chemoradiation for Unresectable Stage III Non-Small Cell Lung Cancer: Inferior Outcomes and Lack of Health Equity in Hispanic Patients Treated With PACIFIC Protocol (LA1-CLICaP)Luis E Raez, Oscar Arrieta, Diego F Chamorro, et al.
The Lancet. Healthy Longevity|May 5, 2024
Social health and subsequent cognitive functioning in people aged 50 years and older: examining the mediating roles of depressive symptoms and inflammatory biomarkers in two European longitudinal studiesJean Stafford, Serhiy Dekhtyar, Anna-Karin Welmer, et al.
Brain Sciences|September 23, 2022
What Do We Know about Social and Non-Social Factors Influencing the Pathway from Cognitive Health to Dementia? A Systematic Review of ReviewsMarta Lenart-Bugla, Mateusz Łuc, Marcin Pawłowski, et al.
Pageof 6